Financial results - CABINET DR. ŢANE SRL

Financial Summary - Cabinet Dr. Ţane Srl
Unique identification code: 18696496
Registration number: J09/428/2006
Nace: 8621
Sales - Ron
117.371
Net Profit - Ron
72.600
Employee
2
The most important financial indicators for the company Cabinet Dr. Ţane Srl - Unique Identification Number 18696496: sales in 2023 was 117.371 euro, registering a net profit of 72.600 euro and having an average number of 2 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala generala having the NACE code 8621.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Cabinet Dr. Ţane Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 43.223 48.572 48.032 50.231 56.536 67.813 74.867 82.600 89.356 117.371
Total Income - EUR 43.223 48.572 48.032 50.232 56.644 68.129 74.954 82.631 89.404 119.682
Total Expenses - EUR 41.136 41.088 41.143 45.157 45.052 48.770 50.843 48.673 64.327 45.885
Gross Profit/Loss - EUR 2.088 7.484 6.890 5.075 11.592 19.358 24.111 33.958 25.077 73.797
Net Profit/Loss - EUR 791 6.027 6.409 4.572 11.028 18.677 23.362 33.131 24.183 72.600
Employees 3 3 3 3 3 3 3 3 6 2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 31.8%, from 89.356 euro in the year 2022, to 117.371 euro in 2023. The Net Profit increased by 48.491 euro, from 24.183 euro in 2022, to 72.600 in the last year.

Check the financial reports for the company - Cabinet Dr. Ţane Srl

Rating financiar

Financial Rating -
Cabinet Dr. Ţane Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Cabinet Dr. Ţane Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Cabinet Dr. Ţane Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Cabinet Dr. Ţane Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Cabinet Dr. Ţane Srl - CUI 18696496

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 15.276 9.635 5.723 2.778 3.271 3.543 2.880 4.298 3.309 6.039
Current Assets 3.217 4.490 7.909 8.973 15.147 23.139 27.881 35.571 28.840 88.047
Inventories 0 0 0 0 0 0 0 0 0 0
Receivables 2.405 2.456 2.169 2.521 3.286 4.002 4.433 4.027 6.418 67.364
Cash 812 2.034 5.740 6.452 11.861 19.137 23.448 31.544 22.423 20.683
Shareholders Funds 4.908 10.179 10.519 8.612 14.993 23.096 27.177 36.862 27.925 76.331
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 13.585 3.946 3.113 3.139 3.424 3.585 3.584 3.007 4.224 17.755
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8621 - 8621"
CAEN Financial Year 8621
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 88.047 euro in 2023 which includes Inventories of 0 euro, Receivables of 67.364 euro and cash availability of 20.683 euro.
The company's Equity was valued at 76.331 euro, while total Liabilities amounted to 17.755 euro. Equity increased by 48.491 euro, from 27.925 euro in 2022, to 76.331 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Cabinet Dr. Ţane Srl

Comments - Cabinet Dr. Ţane Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.